Drug
Avi 7537
Avi 7537: highest development phase Phase 1, developed by Sarepta Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Sarepta Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| AVI-7537 NCT01593072 | Phase 1 | Ebola Hemorrhagic Fever |
Latest
No recent events.
Follow Avi 7537 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.